Canada bans bisphenol A
Canada has become the first country in the world to declare bisphenol A (BPA) as a toxic substance under the Canadian Environmental Protection Act.
Canada has reportedly become the first country in the world to declare bisphenol A (BPA) as a toxic substance under the Canadian Environmental Protection Act. BPA, commonly used in the manufacture of plastics, has been linked to a wide range of health disorders, including prostate and breast cancer because of its ability to mimic the hormone oestrogen. The Canadian governmental agencies evaluated BPA in infant milk bottles, plastic bottles and also the lining of cans. In the latter case, BPA is used as an epoxy to help in the preservation of canned foods and there are reports that trace amounts can leak into the food resulting in prolonged exposure for humans.
Dionex has announced that it has developed a fast and accurate screening method for detecting BPA in food and beverage containers. In addition, several demonstrated applications including the recovery of BPA from canned tuna and phenols in drinking water are reported to be available. Methods using mass spectrometric detection have been developed for rapid automated testing for BPA without sample preparation or preconcentration, for use in the testing of bottled water, consumer products and infant feeding bottles.
For information on these applications visit www.dionex.com
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
